Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

Measles: the UK’s next epidemic?

March 6, 2024
| MMR, measles, vaccines

Recently, the UK has seen a rapid increase in the number of cases of measles, along with a drop in …

Feature

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

February 20, 2023
Business Services |

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …

Feature
Case study

Veeva la Vida: A Roundup of the R&D and Quality Summit 2022

June 30, 2022
|

Timeline On the 8 June, we had the pleasure of joining Veeva at their 2022 Life Sciences Summit in Zurich, …

Feature

Appy Days: How the smartphone app is revolutionising mental healthcare

May 6, 2022
|

Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …

Feature

Injecting real-world data into every day clinical trials – RWE and RWD

March 29, 2022
|

The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …

Feature

Preparation Preconditions: What measures are needed to combat another pandemic?

March 29, 2022
|

Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …

Feature

Shaping the new frontiers of women’s health

March 16, 2022
|

 March 8 was International Women’s Day and provided a perfect opportunity for Pharmafocus to dive deep into women’s health. Lina …

Feature

Technology on trial – the latest cogs in the clinical machine

February 1, 2022
|

From the integration of social media to everyday life, to the seeping of AI into our daily lives, the past …

Feature

Access denied: Is Brexit spelling bedlam for UK clinical trials?

February 1, 2022
|

Since Article 50 was triggered on the 29 March 2017, the UK’s pharmaceutical industry collectively held its breath, bracing itself …

Feature

Maintaining product authenticity: The solution to a serial problem

December 6, 2021
Sales and Marketing |

Counterfeit medicines pose a serious risk to public safety, and, in some cases, can lead to serious adverse effects (SAE) …

Feature

Sidelined or streamlined? Diabetic care and COVID-19

December 6, 2021
Sales and Marketing |

The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …

Feature

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Feature

Debunking vaccine myths and growing concerns

September 28, 2021
Manufacturing and Production |

Before the COVID-19 pandemic, vaccines were never seen as a quick fix. Preventative vaccines for Ebola, malaria, and the Zika …

Feature
33482625641_c7347cbaba_h

AI and neurology: How machine learning is revolutionising neuroscience

September 28, 2021
Manufacturing and Production |

 

Feature
Load more Feature Articles

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024